| Literature DB >> 17157040 |
Huazhang An1, Wei Zhao, Jin Hou, Yan Zhang, Yun Xie, Yuejuan Zheng, Hongmei Xu, Cheng Qian, Jun Zhou, Yizhi Yu, Shuxun Liu, Gensheng Feng, Xuetao Cao.
Abstract
The Toll-like receptor 3 (TLR3) and TLR4-signaling pathway that involves the adaptor protein TRIF activates type I interferon (IFN) and proinflammatory cytokine expression. Little is known about how TRIF pathway-dependent gene expression is regulated. SH2-containing protein tyrosine phosphatase 2 (SHP-2) is a widely expressed cytoplasmic tyrosine phosphatase. Here we demonstrate that SHP-2 negatively regulated TLR4- and TLR3-activated IFN-beta production. SHP-2 inhibited TLR3-activated but not TLR2-, TLR7-, and TLR9-activated proinflammatory cytokine IL-6 and TNF-alpha production. SHP-2 inhibited poly(I:C)-induced cytokine production by a phosphatase activity-independent mechanism. C-terminal domain of SHP-2 directly bound TANK binding kinase (TBK1) by interacting with the kinase domain of TBK1. SHP-2 deficiency increased TBK1-activated IFN-beta and TNF-alpha expression. TBK1 knockdown inhibited poly(I:C)-induced IL-6 production in SHP-2-deficient cells. SHP-2 also inhibited poly(I:C)-induced activation of MAP kinase pathways. These results demonstrate that SHP-2 specifically negatively regulate TRIF-mediated gene expression in TLR signaling, partially through inhibiting TBK1-activated signal transduction.Entities:
Mesh:
Substances:
Year: 2006 PMID: 17157040 DOI: 10.1016/j.immuni.2006.10.014
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745